ENOVIS CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.26 USD | +0.29% |
|
-1.02% | -1.36% |
Chart calendar Enovis Corporation
45e4d904842f.y4MozB7FbW27bf7c0EWlDwYkG6q-4VAuUUDTzsqgtoY.uNMZ9SyjXAPsJJ2VqAyTam19UNzPiiRMY22n_br54cSk0kuqcaQ1XdIppw~d1dc09d9ea27d89be2d4ea489ef3990d
Upcoming events on Enovis Corporation
Past events on Enovis Corporation
| 10/04/2024 01:15 am | Needham Healthcare Conference |
| 22/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 22/02/2024 04:30 pm | Q4 2023 Earnings Release |
| 15/02/2024 | American Academy of Orthopaedic Surgeons Conference |
| 13/02/2024 04:00 am | Canaccord Genuity Musculoskeletal Conference |
| 01/02/2024 | American College of Foot And Ankle Surgeons Meeting |
| 08/01/2024 11:15 pm | JPMorgan Healthcare Conference |
| 29/11/2023 08:30 pm | Evercore ISI HealthCONx Conference |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 07/11/2023 04:30 pm | Q3 2023 Earnings Release |
| 02/11/2023 | American Association of Hip and Knee Surgeons Meeting |
| 25/09/2023 06:00 pm | Acquisition of LimaCorporate S.p.A. by Enovis Corp Call |
| 20/09/2023 | American Orthopedic Foot and Ankle Society Meeting |
| 12/09/2023 06:00 pm | Baird Global Healthcare Conference |
| 09/08/2023 09:00 pm | Canaccord Genuity Growth Conference |
| 03/08/2023 06:00 pm | Q2 2023 Earnings Call |
| 03/08/2023 03:30 pm | Q2 2023 Earnings Release |
| 13/07/2023 | American Orthopedic Society of Sports Medicine Meeting |
| 22/06/2023 | JMP Securities Mid-Year MedTech Forum |
| 21/06/2023 | NATA Conference |
Past dividends on Enovis Corporation
| 05/04/2022 | 0 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 327 3 366 -1.14% | 3 071 3 071 0.01% | 3 854 3 840 0.36% | 1 563 1 570 -0.45% | 1 707 1 698 0.57% | 2 118 |
|
EBITDA Million USD | Released Forecast Spread | 505 582 -13.18% | 463 462 0.19% | 623 610 2.17% | 236 236 0.04% | 269 267 0.69% | 373 |
|
EBIT Million USD | Released Forecast Spread | 269 309 -13.1% | 217 213 1.8% | 360 327 10.29% | 159 160 -0.65% | 186 158 17.45% | 257 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 50,5 52,4 -3.72% | 58,0 81,8 -29.05% | 165 193 -14.09% | -2,07 5,35 -138.67% | -67,1 -81,4 17.53% | 3,98 |
|
Net income Million USD | Released Forecast Spread | -528 -455 -15.95% | 42,6 51,2 -16.71% | 71,7 142 -49.65% | -13,3 49,9 -126.66% | -33,3 -42,0 20.85% | 23,4 |
|
EPS USD | Released Forecast Spread | -11,7 -9,89 -18.06% | 0,93 1,17 -20.38% | 1,38 2,78 -50.43% | -0,25 0,91 -127.47% | -0,61 -0,84 26.95% | 1,09 |
| Announcement Date | 21/02/20 | 18/02/21 | 22/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 023 1 009 1.43% | 376 367 2.2% | 395 400 -1.28% | 384 382 0.47% | 409 416 -1.7% | 406 390 4.15% | 429 419 2.32% | 418 414 0.77% | 455 445 2.16% | 506 | 533 | 516 | 564 | 548 |
|
EBITDA Million USD | Released Forecast Spread | 157 165 -4.76% | 47,7 44,3 7.8% | 56,2 56,0 0.31% | 57,2 54,8 4.46% | 74,9 75,1 -0.23% | 56,4 51,6 9.3% | 65,7 62,4 5.37% | 65,4 63,8 2.44% | 81,7 79,8 2.42% | 80,2 | 93,3 | 90,8 | 109 | 87,8 |
|
EBIT Million USD | Released Forecast Spread | 91,4 93,2 -1.93% | 29,1 27,8 4.86% | 36,7 38,5 -4.61% | 39,1 35,9 8.69% | 54,3 56,1 -3.21% | 36,4 31,2 16.52% | 44,9 41,1 9.14% | 43,9 42,5 3.34% | 60,3 50,5 19.49% | 52,8 | 64,2 | 61,4 | 78,9 | 58,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 39,8 93,3 -57.34% | -46,2 -21,0 -120% | 116 11,8 886.78% | -78,3 13,1 -696.03% | -2,54 4,90 -151.84% | -30,0 -17,8 -68.78% | -19,3 -2,58 -650.41% | -25,5 -13,2 -93.69% | 7,66 7,77 -1.49% | -9,99 | 0,77 | -2,60 | 15,8 | -4,20 |
|
Net income Million USD | Released Forecast Spread | -1,91 66,7 -102.86% | -39,4 -12,1 -225.62% | 76,9 13,2 483.71% | -66,6 9,80 -779.71% | -38,6 14,9 -358.5% | -23,4 -14,2 -64.44% | -10,00 2,20 -554.32% | -2,88 -3,70 22.16% | 2,96 6,18 -52.07% | -2,79 | 5,64 | 3,30 | 17,3 | -3,30 |
|
EPS USD | Released Forecast Spread | -0,03 1,19 -102.52% | -0,72 -0,22 -229.21% | 1,41 0,27 428.74% | -1,23 0,18 -796.21% | -0,71 0,27 -359.76% | -0,43 -0,26 -65.38% | -0,18 0,04 -573.68% | -0,05 -0,07 25% | 0,05 0,15 -67.21% | 0,11 | 0,27 | 0,23 | 0,49 | 0,23 |
| Announcement Date | 22/02/22 | 10/05/22 | 04/08/22 | 02/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 07/11/23 | 22/02/24 | - | - | - | - | - |
| 29/04/2024 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | STRYKER CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
| 01/05/2024 11:30 am | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 02/05/2024 01:35 am | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | AXONICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 03:30 pm | ENOVIS CORPORATION: Q1 2024 Earnings Release |
| 06/05/2024 | ORTHOPEDIATRICS CORP.: Q1 2024 Earnings Release |
Past sector events for Enovis Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENOV Stock
- Calendar Enovis Corporation
